Exchange transfusion in complicated pediatric malaria: A critical appraisal

Area of Science:

• Pediatrics
• Infectious Diseases
• Hematology

Background:

• Severe falciparum malaria presents a high mortality risk despite standard treatments.
• The role of exchange blood transfusion (EBT) as an adjunct therapy for severe malaria remains debated.
• Evidence on the efficacy and safety of EBT in pediatric severe malaria requires critical appraisal.

Purpose of the Study:

• To critically review current evidence on the use of exchange blood transfusion for severe malaria in children.
• To assess the impact of EBT on parasite clearance and patient survival.
• To identify potential complications associated with EBT in this population.

Main Methods:

• Systematic literature search for pediatric cases of severe malaria treated with exchange blood transfusion.
• Analysis of 23 identified cases from 9 published reports.
• Evaluation of pre- and post-procedure parasite index (PI) and patient outcomes.

Main Results:

• A total of 23 pediatric patients with severe falciparum malaria treated with EBT were analyzed.
• The average pre-EBT parasite index was 41.4%, with an average blood volume exchange of 118.6%.
• Post-EBT, a mean reduction of 34.1% in parasite index was observed, and all 23 children survived, with 3 experiencing minor complications.

Conclusions:

• Exchange blood transfusion appears to be a safe and potentially effective adjunctive treatment for severe falciparum malaria in children.
• EBT can significantly reduce parasite burden, contributing to improved survival rates.
• Further research with larger cohorts is warranted to solidify the role of EBT in managing severe pediatric malaria.